Zymochem company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Seed VC | Alive

Total Raised


Last Raised

$4M | 6 mos ago

About Zymochem

Zymochem is developing novel biosynthetic pathways, engineering next-generation microbes, and establishing cost-advantaged bioprocesses for the biological conversion of sugars and other bio-based feedstocks into various industrial chemicals used in the manufacturing of consumer products.

Zymochem Headquarter Location

1933 Davis St.

San Leandro, California, 94577,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Zymochem

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Zymochem is included in 3 Expert Collections, including Synthetic Biology.


Synthetic Biology

305 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



275 items

Zymochem Patents

Zymochem has filed 2 patents.

The 3 most popular patent topics include:

  • Alkanes
  • Alkanols
  • EC 2.7.1
patents chart

Application Date

Grant Date


Related Topics



Alkanes, EC 2.7.1, Fatty alcohols, Alkanols, Primary alcohols


Application Date


Grant Date


Related Topics

Alkanes, EC 2.7.1, Fatty alcohols, Alkanols, Primary alcohols



Latest Zymochem News

ZymoChem Completes $4 Million Seed Financing

Dec 8, 2021

ZymoChem Completes $4 Million Seed Financing December 8, 2021 SAN FRANCISCO BAY AREA – ZymoChem, Inc. , an early-stage bioproducts company engineering microbial-based processes for manufacturing industrial chemicals and crafting high-performance materials, today announced that it has closed a $4 million Seed financing. New investors of ZymoChem include Breakout Ventures , Cavallo Ventures , GS Futures , KdT Ventures , and Litani Ventures , along with existing investor SOSV ’s IndieBio . Proceeds from the round will be used to scale ZymoChem’s bioprocesses for multiple commercial products and expand the R&D and Business Development teams. This financing brings the total raised to $18 million to-date, including $13 million in non-dilutive funding from US government grants and ZymoChem’s first partnership with a large chemicals conglomerate. “ZymoChem’s carbon-efficient biotechnology reduces carbon waste and can be scaled for bio-based production of chemicals at incredibly low costs – a true game changer for decreasing the carbon footprint of the chemicals industry,” said Harshal Chokhawala , President and CEO of ZymoChem. “2022 is a very exciting year for ZymoChem. We are doubling our team size, scaling up our carbon-efficient biomanufacturing processes for multiple products, and broadening our C2 technology’s impact through additional partnerships to expand the available high-performance, sustainable products on the market.” ZymoChem is a biotechnology-centric chemicals company focused on designing fermentation processes and manufacturing high-performance materials that go into everyday consumer goods. The company works with industry-leading partners to introduce novel bio-based products with high growth market opportunities where performance, bio-content, and sustainability are key. ZymoChem’s mission is realized through its proprietary Carbon Conservation (C2) Microbes and biotechnology platform that enable rapid development of scalable fermentation processes operating at cutting-edge efficiencies while delivering substantially lower costs than the incumbent processes. “ZymoChem is the perfect example of where we are seeing biology, chemistry, and technology converge to create bio-based solutions for our planet,” said Lindy Fishburne , Managing Partner of Breakout Ventures. “We are excited to partner with the company as they begin scaling their fermentation processes to secure a sustainable future.” “ZymoChem is re-thinking how to build a Proctor & Gamble for the 21st century. By hiring world-class biotechnology talent that can design and engineer bio-based, hero ingredients into everyday products, ZymoChem is paving the way for a new, more sustainable chemicals industry,” said Phil Grayeski , Partner of KdT Ventures. “No longer do we need to exploit fossil fuels to manufacture everyday goods. We’ve been incredibly impressed by ZymoChem’s growth, technology, and their vision. There is lots of exciting news coming soon that will disrupt how we think about our everyday consumer goods.” ABOUT information about ZymoChem, Inc. and open roles, please visit www.zymochem.com.

Zymochem Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Zymochem Rank

  • When was Zymochem founded?

    Zymochem was founded in 2013.

  • Where is Zymochem's headquarters?

    Zymochem's headquarters is located at 1933 Davis St., San Leandro.

  • What is Zymochem's latest funding round?

    Zymochem's latest funding round is Seed VC.

  • How much did Zymochem raise?

    Zymochem raised a total of $4.47M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.